Results 221 to 230 of about 50,591 (247)

Comparative Tear Fluid Proteomics to Explore Treatment Responsiveness in Diabetic Macular Edema: A Pilot Study. [PDF]

J Proteome Res
Ma IH, Hsu YL, Wu HY, Hsieh YT, Pan SH.
europepmc   +1 more source

What Lies beneath Diabetic Macular Edema: Latent Phenotypic Clustering and Differential Treatment Responses to Intravitreal Therapies. [PDF]

Ophthalmol Sci
Cicinelli MV, Leonardo B, Maiucci G, Martino G, Ziafati M, Bousyf S, Frizziero L, Lattanzio R, Midena E, Bandello F.   +9 more
europepmc   +1 more source

Gene Therapy in Diabetic Retinopathy and Diabetic Macular Edema: An Update. [PDF]

J Clin Med
Odio-Herrera M, Orozco-Loaiza G, Wu L.
europepmc   +1 more source

Predictive value of hyperreflective foci for anti-VEGF therapeutic outcomes in different subtypes of diabetic macular edema: a retrospective analysis. [PDF]

Front Endocrinol (Lausanne)
Wang Y, Li F, Hao M, Kong X, Zhou W.
europepmc   +1 more source

Comparing intravitreal bevacizumab and sub threshold macular laser (STML) in the initial treatment of diabetic macular edema (DME) in a resident lead clinic.

, 2018
Mansoor Mughal, Ryan Phan, Eileen Chang, Gregory D. Kramer, J. Alexander, Marcelle Morcos   +5 more
openalex   +1 more source

Blood Pressure Status Modulates the Therapeutic Response to Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial. [PDF]

J Diabetes
Ishibashi R, Koshizaka M, Takatsuna Y, Tatsumi T, Baba T, Yamamoto S, Yokote K.   +6 more
europepmc   +1 more source

Erratum in: Comments on "Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema". [PDF]

Invest Ophthalmol Vis Sci
europepmc   +1 more source

Diagnostic Accuracy of Artificial Intelligence in Predicting Anti-VEGF Treatment Response in Diabetic Macular Edema: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Al-Harbi FA, Alkuwaiti MA, Alharbi MA, Alessa AA, Alhassan AA, Aleidan EA, Al-Theyab FY, Alfalah M, AlHaddad SM, Azzam AY.   +9 more
europepmc   +1 more source

Short-term efficacy and safety of intravitreal brolucizumab in diabetic macular edema: A retrospective interventional study.

Oman J Ophthalmol
Mal W, Al-Abri M, Al Fadhil NA, Jaju S, Al-Riyami ASAS.   +4 more
europepmc   +1 more source

Real-World Clinical Outcomes After Sustained Delivery of the 0.19 mg Fluocinolone Acetonide Implant for Treatment of Diabetic Macular Edema. [PDF]

J Vitreoretin Dis
Godel S, Oncel D, Donkor R, Coney JM.
europepmc   +1 more source